Indian pharma firm told to pay Rs 363 crore fine for destroying records before USFDA inspection
As a part of a criminal resolution, FKOL agreed to plead guilty to the misdemeanour offense, pay a criminal fine of USD 30 million, and forfeit an additional USD 20 million.;
Advertisement
Washington: An Indian drug manufacturer has agreed to plead guilty to concealing and destroying records prior to a 2013 US Food and Drug Administration's inspection of its plant and pay USD 50 million in fines and forfeiture, the Department of Justice has announced.
In a criminal information filed in federal court in the District of Nevada and unsealed on Tuesday, Fresenius Kabi OncPTIology Limited (FKOL) was charged with violating the Federal Food, Drug, and Cosmetic Act by failing to provide certain records to Food and Drug Administration's (FDA) investigators.
As part of a criminal resolution, FKOL agreed to plead guilty to the misdemeanor offense, pay a criminal fine of USD 30 million, and forfeit an additional USD 20 million.
FKOL also agreed to implement a compliance and ethics program designed to prevent, detect, and correct violations of US law relating to FKOL's manufacture of cancer drugs intended for terminally ill patients, a media release said.
"By hiding and deleting manufacturing records, FKOL sought to obstruct the FDA's regulatory authority and prevent the FDA from doing its job of ensuring the purity and potency of drugs intended for US consumers," said Acting Assistant Attorney General Brian Boynton of the Justice Department's Civil Division.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.